MenACWY-CRM conjugate vaccine

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines

Conditions

Meningococcal MeningitisN. Meningitidis Carriage

Phase 3

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

CompletedNCT00856297

Novartis VaccinesMeningococcal Meningitis

Start: 2009-02-28End: 2012-11-30Updated: 2017-06-14

Novartis Vaccine and Diagnostics Carriage Trial

CompletedNCT01214850

Novartis VaccinesN. Meningitidis Carriage

Start: 2010-09-30End: 2012-01-31Updated: 2016-04-21

Related Papers

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.

2014-08-18212 citations